Skip to main content
logo
Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
14.24
+0.28 (2.01%)
Sep 5, 2025, 5:30 PM CET

SWX:SANN Revenue

In the year 2024, Santhera Pharmaceuticals Holding AG had annual revenue of 39.12M CHF, down -62.17%. Santhera Pharmaceuticals Holding AG had revenue of 25.00M in the half year ending December 31, 2024, with 1,944.40% growth.

Revenue
39.12M
Revenue Growth
-62.17%
P/S Ratio
4.63
Revenue / Employee
495.15K
Employees
79
Market Cap
181.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202439.12M-64.30M-62.17%
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-568.53%
Dec 31, 2021-1.60M-16.60M-110.63%
Dec 31, 202015.01M-60.37M-80.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Roche Holding AG63.49B
Novartis AG43.89B
Lonza Group AG7.09B
Galderma Group AG3.73B
Alcon7.97B
Sandoz Group AG8.42B
Straumann Holding AG2.58B
Sonova Holding AG3.87B
Revenue Rankings

Santhera Pharmaceuticals Holding AG News

More News